2-amino-4,5-methyleneadipic acid compounds for treatment of CNS disorders
申请人:G.D. Searle & Co.
公开号:EP0342558B1
公开(公告)日:1994-02-02
PROBENECID FOR USE IN TREATING EPILEPTIC DISEASES, DISORDERS OR CONDITIONS
申请人:Paris Sciences et Lettres - Quartier Latin
公开号:EP3651758A1
公开(公告)日:2020-05-20
US5177109A
申请人:——
公开号:US5177109A
公开(公告)日:1993-01-05
[EN] PROBENECID FOR USE IN TREATING EPILEPTIC DISEASES, DISORDERS OR CONDITIONS<br/>[FR] PROBÉNÉCIDE POUR UTILISATION DANS LE TRAITEMENT DE MALADIES, TROUBLES OU AFFECTIONS ÉPILEPTIQUES
申请人:PARIS SCIENCES LETTRES QUARTIER LATIN
公开号:WO2019012109A1
公开(公告)日:2019-01-17
The present invention relates to probenecid or a pharmaceutical acceptable salt thereof for use in the treatment of a neurological disorder in a subject in need thereof, wherein administration of probenecid or a pharmaceutical acceptable salt thereof controls clinical or electrographic seizures in said subject. Preferably, said neurological disorder is an epileptic disease, disorder or condition.
Pellicciari; Natalini; Marinozzi, Il Farmaco, 1991, vol. 46, # 11, p. 1243 - 1264